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Summary.-Effects of neonatal androgenization or neonatal ovariectomy in female
rats on endocrine functions and mammary tumourigenesis are examined. Pituitary
gonadotrophin contents (both LH and FSH) are significantly lower in neonatally
androgenized rats (TT) and significantly increased in neonatally ovariectomized
rats (NO) when compared with controls of the sameage. Plasma and pituitary pro-
lactin levels are higher in TT rats than in the control rats of the same age, but the
difference is not significant. Mammary tumours developing in TT rats after DMBA
treatment are predominantly fibroadenomata, and lactogenesis in TT rats occurs
almost entirely in those receiving DMBA treatment. Neonatal ovariectomy in
female rats protects against subsequent induction of mammary cancer by DMBA.
Therelationship between neonatal modification ofendocrine functions and mammary
tumourigenesis is discussed.
A SINGLE injection of testosterone
given to female rats during the first
10 days oflife induces permanent morpho-
logical and functional changes in the
gonadotrophin-ovarian axis. Endocrine
abnormalities such as small polyfollicular
ovaries lacking corpora lutea, lowpituitary
luteinizing hormone content, low plasma
oestrogen level and constant vaginal
cornification, have been regularly ob-
served in these neonatally testosterone-
treated (TT) rats (Barraclough, 1967;
Gorski and Barraclough, 1962; Mallampati
and Johnson, J973).
The effect of these hormonal altera-
tions on mammary tumourigenesis, how-
ever, has not been examined in depth,
even though ovarian and pituitary hor-
mones are critically involved in the
induction of mammary tumours in the
rat (Clemens, Welsh and Meites, 1968;
Dao, 1962). In this investigation, the
effects of neonatal testosterone treatment
and neonatal ovariectomy on pituitary
and gonadal function are examined in
detail and are correlated with the effect
of the carcinogen 7,12-dimethylbenz(Q)-
anthracene (DMBA) on the induction
of mammary tumours.
MATERIALS AND METHODS
Animals.-Atotal of150 Sprague-Dawley
female rats (Holtzman Company, Madison,
Wisconsin) were used in this study. All
newborns used for this investigation were
obtainedin our ownlaboratory. The animals
were kept under conditions of rhythmic
artificial illumination (14 h/day) and were
housed in a temperature-controlled room
(22 ± 1°C). A diet of Rockland pellets and
water was provided ad libitum.
Experimental.-Female rats were neo-
natally sterilized by either a single s.c.
injection of 1 25 mg testosterone propionate
dissolved in 0 05 ml olive oil within 24 h
of their birth, or by the removal of the
ovaries at 5 days of age. At 55 days of
age, 32 neonatally testosterone-treated (TT),
10 neonatally ovariectomized (NO), and 30
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untreated control rats were given a single
i.v. injection of 1 ml of a lipid emulsion
containing 5 mg of DMBA. These animals
were examined for tumours once weekly.
Tumours were measured in two dimensions
with a vernier caliper. At the time of
autopsy (90 days after carcinogen administra-
tion), tumours were removed, fixed in
Bouin's solution, and sections prepared and
stained with haematoxylin and eosin. For
comparison, 10 TT, 10 NO, and 10 control
rats without DMBA treatment were sacrificed
at 60 and 150 days of age. Vaginal smears
were taken regularly in control animals and,
when possible, in NO and TT rats, since most
of them have pinpoint vaginal openings.
Blood was collected for prolactin assay by
cardiac puncture under ether anaesthesia
using a heparinized needle and syringe.
Control pituitaries were collected when the
rats were in oestrus since TT rats have a
constant oestrus vaginal smear pattern,
due to their anovulatory polyfollicular state
(Barraclough, 1967). The anterior pituitaries
were individually weighed, and both plasma
and anterior pituitaries were frozen immedi-
ately at -20°C until the time of prolactin
assay. In another set of experiments, pitui-
tary gonadotrophins including FSH and LH
in TT and NO rats were compared with
that in the control rats. Morphology of the
mammary gland and the gonads from these
three groups of animals was also studied.
Prolactin assay.-Prolactin of individual
plasma samples and pituitaries was measured
by a radioimmunoassay described previously
by Niswender et al. (1969). Sheep anti-
rabbit globulin was purchased from Grand
Island Biological Company (Grand Island,
New York). Anti-rat-prolactin reference
standard and rat prolactin for iodination
were kindly supplied by the National
Institute of Arthritis, Metabolic and Diges-
tive Diseases (rat pituitary distribution
programme). Data from radioimmunoassay
were subjected to analysis of variance.
Assay of pituitary FSH and LH.-
Pituitary luteinizing hormone (LH) content
was determined by the method described
by Parlow (1961). This method is based
on the ability of LH to deplete ascorbic
acid in the copora lutea of immature (21-22-
day-old) pseudopregnant rats. The assay
is specific since other pituitary trophic
hormones, such as follicle stimulating hor-
mone, prolactin and ACTH, have no effect
on ascorbic acid content in the corpora
lutea.
Pituitary follicle stimulating hormone
(FSH) was assayed by the modification
(Parlow and Reichert, 1963) of the method
originally described by Steelman and Pohley
(1953). This method is based on the increase
in ovarian weights after injection ofpituitary
extracts in 21-22-day-old female rats. The
standard curve is constructed by the changes
in ovarian weights in response to injections
of a mixture of standard FSH (NIH-FSH-S8)
at different dose levels and 50 iu of HCG.
HCG is used to augment the increase in
ovarian weights induced by FSH.
RESULTS
Morphological studies of the mammary
glands, gonads, and pituitaries in TT,
NO and control rats
There is no difference in the morph-
ology of mammary glands in TT and
control rats. In NO rats the mammary
glands are atrophic. The weights of the
ovaries, uteri, adrenal glands and pitui-
taries in TT and NO rats at 60 and 150
days and their respective controls are
summarized in Table I. The ovarian
TABLE I.- Endocrine Organs in Control, Neonatally Androgenized (TT) and Neonatally
Ovariectomized (NO) Rats
Mean organ weight ± standar(d error
(mg/l 00 g)
Ovary Uterine horn Adrenal
30-90±1-19 147-60±-5-92 29-9±0-79
12-10-40-59 102-90+4-29 25-1_]±0-91
- 21-1 I3-19 23 0+41-49
36 30+1 23 232.32-7 13 35-9±0-87
15-50±1-33 149-3±5-87 35-2±1-17
23-9+1-34 32 9+0 69
Age
(days)
60
60
60
150
150
t5O
Group
Control
TT
NO
Control
TT
NO
Pituitary
87-'-042
10-2 + 0-86
9 -1±0-62
11 91* 19
14-8-10-89
14-1 +0-42
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and uterine weights in TT rats at both 60
and 150 days are significantly lower than
their respective controls (P < 0 001). The
adrenal weights show no change as a
result of neonatal treatment with testo-
sterone or removal of the ovaries. The
pituitaries of TT and NO rats are larger
than their controls at 150 days, but
these differences are not significant.
Histological examination reveals that
ovaries of TT rats contain follicles but
no corpus luteum. Occasionally, atretic
follicles are visible in the sections. Uterine
horns are smaller in the TT rats as com-
pared with those of normal females of
the same age. Histological examination
reveals that the uterine epithelial layer
in TT rats is composed of tall columnar
epithelial cells. In addition, islands of
squamous metaplasia are frequently seen.
The endometrial stroma is compact and
has few glands. However, the myo-
metrium of the uterine horns is similar
in appearance to that of normal females.
NO rats have atrophic uteri. Both endo-
metrium and myometrium are thin and
practically no glands have ever been
observed in these sections. The pitui-
taries from TT rats are morphologically
similar to those from the controls. Those
from NO rats, however, have markedly
hypertrophied basophils, a typical castra-
tion effect.
Pituitary gonadotrophin content in NO,
TT and control rats
The results are summarized in Table
II. Pituitary luteinizing hormone con-
centration in TT rats is about 5000 that
of normal females. This is true both
at 60 (P < 0.01) and 150 (P < 0-001)
days. LH concentration in the pituitary
of NO rats, however, is increased 7- and
5-fold over normal females at 60 and 150
days of age, respectively. FSH content
is lower in the pituitaries of TT rats
than in the control rats, but the difference
is significant only at 150 days. There
is a significant increase of FSH in the
pituitaries of NO rats.
Pituitary and plasma prolactin concentra-
tions in controls, TT and NO rats
Results shown in Table II demonstrate
that the pituitary prolactin levels in TT
rats are slightly lower than the control
oestrus females at both 60 and 150 days.
These differences, however, are not sta-
tistically significant. The pituitary pro-
lactin in the NO rats, however, is signifi-
cantly lower than in the control rats
(P < 0'001 at 60 days and P < 0 005
at 150 days). Treatment with DMBA
does not induce any significant change
in the level of pituitary prolactin in
either the control or TT rats at 150 days.
The figure shows that plasma prolactin
concentration is higher in TT rats than
in the controls at both 60 and 150 days.
This apparent increase in plasma prolactin
concentration, however, is not statistically
significant. The NO rats, on the other
hand, have plasma prolactin levels that
are 25% of the control value at 60 days
(P < 0.001) and 20% of the control
value at 150 days (P < 0.005). The plas-
ma prolactin concentrations in rats given
TABLE IT.-Pituitary Gonadotrophin and Prolactin Content in NTO, TT, and
Control Rats
Age
(days)
60
60
60
150
150
150
Group
Control
TT
NOT
Control
TT
NO
LH
(,rig/mg pit.)
1587+0 26
0-96±0 14t
1:3 11 2 2 31
2-17±0-04
1 03 L 0 .008*
11*82-41 *16
FSH
(,Ug/mg pit.)
49--0:31
3 -70 46
26-024- 10
4-1+0-26
2 -04-0*30t
25 * 2 5 5 *10
Prolactin
(,Ug/mg pit.)
2 3+0*41
1 9±0 90
0 3- -0.01*
5-95+0-92
5-600 -055
0*32+0*07t
*P < 0-001.
tP < 0.01.
I Both LH an(d FSH are significantly higher than control or TT rats of the same age group. < 0 001.
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TABLE III. Incidence and Histology of
Mammary Tumours Induced by DMBA
in the Control and Neonatally Androgen-
ized Rats
AGE (DAYS)
Fi..-Plasma prolactin levels in Control, TT and NO
rats at 60 an(l 150 days of age, and DMfBA
treated rats (Control and TT) at 150 (lays.
DMBA are not significantly different
from those of untreated controls and the
untreated TT rats at 150 days. Also,
there does not seem to be any correlation
between tumour size and plasma pro-
lactin. It should be noted that both
plasma and pituitary prolactin levels
rise with the increase in the ages of rats
in the control as well as TT groups. This
observation is in agreement with the
earlier report by Voogt, Chen and Meites
(1970).
Tum?ourigenesis of the mnammary gland in
control, TT and NO rats
The incidence of tumour induction
after DMBA treatment is less in TT rats
than in controls. Results in Table III
show that 20 out of 32 TT rats developed
tumours after DMBA treatment as com-
pared to 28 of 30 control rats. However,
the mean number of tumours per rat
was the same and the growth rate of
tumours in the TT rats did not differ
markedly from that of the control rats.
DMBA failed to induce any tumours in
the NO rats.
The latent period for tumour ap-
pearance in TT rats is longer than that
in the controls. An average of 15 weeks
Groups
Control
TT
N0
No. of
rats
30
32
10
No. of
rats with
tumours
28
20
0
Tumour histology
Adeno- Fibro-
carcinoma adenoma
28 0
7 13
0 0
for the first appearance of a tumour was
observed after DMBA treatment in TT
rats as compared with 11-3 weeks in con-
trols. This difference is statistically sig-
nificant (P < 0.001).
The histology of DMBA-induced mam-
mary tumours in the control and TT
rats was examined and compared. There
was a greater incidence of fibroadenomata
in TT rats (65%) as opposed to the
greater incidence of adenocarcinomata in
the control rats (100%/) (Table III).
The finding that fibroadenomata were
the predominant tumours in TT rats
agrees with the work of Shellabarger and
Soo (1973).
One interesting observation in this
study is the induction of lactogenesis
in the mammary gland of TT rats (810%)
receiving DMBA treatment. This finding
was not made in the normal controls
given DMBA or in TT rats not given
DMBA.
DISCUSSION
The effect of neonatal androgenization
on pituitary gonadotrophin and prolactin
in female rats has been studied by several
investigators. Barraclough (1967) ob-
served a significant reduction in pituitary
LH but not in pituitary FSH in TT
rats. Our findings, however, show that
both LH and FSH in the pituitary of
TT rats are significantly lower than the
control levels. These results are in agree-
ment with data reported by others
(Johnson and Witschi, 1963; Shapiro,
1965). The difference between Barra-
clough's data and those reported in this
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paper and by other investigators may
be attributable to the difference in
methods used for assay of FSH. Barra-
clough used a bioassay method which
may be less sensitive than the method
of Steelman and Pohley used by other
investigators.
It has been suggested that reduction
in LH concentration in the pituitary is
the result of a permanent effect in the
hypothalamus induced by a neonatal
injection of testosterone. Thus, Gorski
and Barraclough (1962) were unable to
induce ovulation in TT rats by electrical
stimulation of the hypothalamus. How-
ever, marked decrease in pituitary LH
content has also been observed in rats
following destruction of the anterior
hypothalamus (Cheng and Johnson, 1974).
Both TT rats, and rats whose anterior
hypothalamus has been destroyed, have
persistant oestrus, non-ovulating poly-
follicular ovaries and, thus, constant
oestrogen secretion. It is possible that
oestrogen feedback on the hypothalamus
prevents storage of LH in the pituitary.
In contrast, in NO rats, both LH and
FSH in the pituitary increase several
fold due mainly to a lack of hormonal
feedback causing release of these gonado-
trophins.
The results obtained in this investiga-
tion using radioimmunoassay show that
there is an apparent increase in serum
prolactin in TT rats at 60 days, above
the level in control rats of the same
age. The difference, however, is not
statistically significant. This finding is
in agreement with the earlier report by
Mallampati and Johnson (1973). In the
present study, the pituitary prolactin
contents in TT rats at both 60 and 150
days are lower than those in the control
rats of the same age, a finding similar to
that reported by Kurcz et al. (1967).
Altogether, these results suggest that
androgenized rats have normal prolactin
synthesis and release. This interpreta-
tion is supported by an observation of
the normal development of mammary
glands in the TT rats as determined by
histological examination, and by the
normal synthesis of casein by the mam-
mary gland of the TT rats (unpublished
data). In the NO rat, the absence of
a feedback of gonadal oestrogen on
the hypothalamus and pituitary causes
a markedly reduced prolactin synthesis
and release.
The critical role of oestrogen in
initiating the induction of mammary
tumours by a chemical carcinogen has
been reported earlier (Dao, 1962). In
this investigation, it is shown that neo-
natal ovariectomy completely prevents
mammary carcinogenesis in these rats,
when adult, and neonatal testosterone
treatment causes a reduction ofmammary
tumour in adult. Our results are in
agreement with reports by other in-
vestigators (Shellabarger and Soo, 1973;
Dao, 1966; Kovac, 1965). In addition,
we also observe a striking difference in
the histopathology of the tumours which
develop in the TT rats as compared to
those in the control rats. The finding
that fibroadenomata are the predominant
tumours in TT rats cannot be readily
explained. It seems that cyclic ovarian
function is essential for induction of
mammary adenocarcinoma, since this
cycling is absent after neonatal testo-
sterone treatment.
Lactogenesis in testosterone-sterilized
rats was first reported by Dao (1966)
and later confirmed by Stern, Mickey and
Osvald (1967) and by Shellabarger and
Soo (1973). Dao and Greiner (1961)
also observed lactogenesis in castrated
male rats bearing ovarian grafts given
3-methylcholanthrene. In this present
investigation, we find that lactogenesis
in the mammary gland develops in TT
rats only after DMBA treatment, and
not in those not given DMBA. Since
TT or castrated male rats with ovarian
grafts have noncyclic ovaries, one would
expect a constant prolactin secretion from
a noncyclic pituitary. DMBA may ini-
tiate lactation by an effect on the hypo-
thalamus (Dao and Sinha, 1975), or it
may exert a direct effect on the mammary
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gland cells, rendering them more sensitive
to lactogenesis by circulating prolactin.
Work is now being carried out in our
laboratory to elucidate these possibilities.
This study was supported by a grant
(CA 14812-1) from the National Cancer
Institute.
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